Albuterol use in pediatric cough
Pro Research Analysisby 
Searched over 200M research papers
Albuterol Use in Pediatric Cough: Efficacy and Safety
Albuterol for Acute Cough in Non-Asthmatic Children
Research shows that oral albuterol does not help reduce the frequency or duration of acute cough in non-asthmatic children. In two randomized studies, children with acute cough who had no history of asthma and a normal chest exam were given either oral albuterol or a placebo for seven days. Both groups had a similar and rapid resolution of cough, but those who received albuterol experienced more side effects, such as shaking or trembling, compared to the placebo group. This suggests that oral albuterol is not effective for treating acute cough in non-asthmatic children and may cause unnecessary side effects Bernard2007Bernard1999.
Albuterol in Infants with Acute Viral Bronchiolitis
A randomized, double-blind, placebo-controlled trial in infants with mild-to-moderate acute viral bronchiolitis found no significant difference in the time to resolution of illness or in secondary outcomes (such as time to normal feeding, sleeping, or resolved cough) between those treated with oral albuterol and those given a placebo. The study concluded that oral albuterol should not be widely used in this patient group, as it does not provide clinical benefit .
Albuterol Use During Pediatric Procedures
In a different context, inhaled albuterol given before tonsillectomy in children significantly reduced the risk of perioperative respiratory adverse events, including coughing, compared to placebo. This suggests that while albuterol may not be effective for treating acute cough in general pediatric populations, it can be beneficial in specific situations, such as preventing respiratory complications during surgery .
Albuterol for Wheezing and Bronchiolitis
There is ongoing debate about the use of albuterol in infants with bronchiolitis. Some centers use it frequently, while others do not, partly due to varying interpretations of clinical guidelines and evidence. Although some studies suggest a trial of albuterol may reduce respiratory distress in infants with bronchiolitis, the overall evidence does not support routine use, especially since relief of respiratory distress is sometimes not considered a patient-centered outcome . Additionally, newer therapies like tiotropium are being explored for episodic wheezing, but albuterol remains a commonly used as-needed medication in these cases .
Safety Considerations with Albuterol Solutions
When using inhaled albuterol, especially in young children, it is important to consider the presence of preservatives like benzalkonium chloride (BAC) in some solutions. BAC can irritate the airways and, in rare cases, may cause bronchospasm. Therefore, the risks and benefits of introducing any chemical into a child’s airway should be carefully weighed .
Conclusion
Oral albuterol does not reduce cough duration or frequency in non-asthmatic children or infants with mild-to-moderate bronchiolitis and may cause side effects. Its use is not recommended for routine management of pediatric cough in these groups. However, inhaled albuterol may have a role in preventing respiratory complications during certain surgical procedures. Safety considerations, including potential airway irritation from preservatives, should always be taken into account when using albuterol in children Bernard2007Bernard1999Woolf2020+4 MORE.
Sources and full results
Most relevant research papers on this topic